NEW YORK (360Dx) – T2 Biosystems reported after the market closed on Tuesday that its fourth quarter revenues rose 87 percent year over year, and beat the consensus Wall Street estimate.

For the three months ended Dec. 31, 2017, the company posted revenues of $1.7 million, compared to $910,000 in the same period the year before. The analysts' average estimate was $1.3 million.

The firm's total revenues also beat its preliminary revenue range of between $1.1 million and $1.3 million announced in January.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.